High Tech Pharm Co., Ltd. (KOSDAQ:106190)

High Tech Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,477	13,076	7,759	3,483	7,880	11,275
Short-Term Investments	330	270	-	-	-	-
Trading Asset Securities	192.37	1,084	-	1,882	-	1,363
Cash & Short-Term Investments	3,000	14,430	7,759	5,365	7,880	12,637
Cash Growth	-79.60%	85.97%	44.63%	-31.92%	-37.64%	1117.51%
Accounts Receivable	22,946	11,319	20,330	24,443	28,476	9,413
Other Receivables	40.24	34.54	27.43	40.1	78.47	58.39
Receivables	22,987	11,354	20,357	24,483	28,555	9,472
Inventory	50,526	43,727	34,813	25,498	14,676	17,708
Prepaid Expenses	1,527	1,476	1,304	1,191	885.83	545.12
Other Current Assets	29.5	4.19	1.13	33.78	43.53	126.73
Total Current Assets	78,069	70,991	64,234	56,571	52,040	40,488
Property, Plant & Equipment	66,610	68,854	72,002	75,001	74,934	80,544
Long-Term Investments	2,408	2,451	3,061	2,076	2,198	1,768
Long-Term Deferred Tax Assets	325.15	685.68	505.05	508.51	1,920	-
Other Long-Term Assets	472.53	714.06	287.6	901.23	1,110	136.16
Total Assets	147,885	143,697	140,090	135,058	132,202	122,937

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8,940	6,628	5,348	8,692	13,130	10,451
Accrued Expenses	911.3	769.29	1,177	1,203	633.1	608.08
Short-Term Debt	-	-	7,940	11,447	10,000	10,000
Current Portion of Long-Term Debt	-	-	-	-	6,337	-
Current Portion of Leases	14.88	21.6	28.37	26.85	23.71	2.2
Current Income Taxes Payable	806.47	1,626	3,293	174.79	214.38	-
Current Unearned Revenue	-	-	-	-	178.69	570
Other Current Liabilities	2,629	3,474	1,160	1,241	1,222	1,072
Total Current Liabilities	13,302	12,519	18,946	22,785	31,738	22,703
Long-Term Debt	-	-	-	5,000	-	5,928
Long-Term Leases	5.7	12.01	33.61	25.78	63.55	47.89
Pension & Post-Retirement Benefits	-	-	-	-	-	147.96
Other Long-Term Liabilities	522.35	493.78	1,372	252.56	461.27	225.66
Total Liabilities	13,830	13,025	20,352	28,064	32,263	29,052

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5,317	5,317	5,317	3,544	3,544	3,544
Additional Paid-In Capital	23,290	23,290	23,290	25,068	25,068	25,068
Retained Earnings	105,454	102,071	91,138	78,382	71,327	65,273
Treasury Stock	-5.35	-5.35	-5.35	-	-	-
Comprehensive Income & Other	0	0	0	0	0	0
Shareholders' Equity	134,055	130,671	119,738	106,994	99,939	93,885
Total Liabilities & Equity	147,885	143,697	140,090	135,058	132,202	122,937

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	20.57	33.61	8,002	16,500	16,424	15,978
Net Cash (Debt)	2,979	14,396	-243.03	-11,135	-8,543	-3,340
Net Cash Growth	-57.11%	-	-	-	-	-
Net Cash Per Share	-	1345.34	-22.86	-1570.78	-803.46	-314.15
Filing Date Shares Outstanding	-	10.63	10.63	7.09	10.63	10.63
Total Common Shares Outstanding	-	10.63	10.63	7.09	10.63	10.63
Working Capital	64,767	58,472	45,288	33,786	20,302	17,786
Book Value Per Share	-	12289.70	11261.43	15093.47	9398.78	8829.44
Tangible Book Value	134,055	130,671	119,738	106,994	99,939	93,885
Tangible Book Value Per Share	-	12289.70	11261.43	15093.47	9398.78	8829.44
Land	8,036	8,036	7,933	7,933	7,880	7,832
Buildings	58,445	58,440	57,923	53,974	52,056	52,671
Machinery	46,016	45,483	45,082	47,960	43,826	43,765
Construction In Progress	24.5	335.5	96	2,326	554	408.55

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error